Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 9/2009

01.09.2009 | Short Communication

18F-Fluoroglucosylation of peptides, exemplified on cyclo(RGDfK)

verfasst von: Christina Hultsch, Margret Schottelius, Jörg Auernheimer, Andrea Alke, Hans-Jürgen Wester

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 9/2009

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Oxime formation between an aminooxy-functionalized peptide and an 18F-labelled aldehyde has recently been introduced as a powerful method for the rapid one-step chemoselective synthesis of radiofluorinated peptides.

Materials and methods

Here, the potential of using routinely produced and thus readily available [18F]fluorodeoxyglucose ([18F]FDG) as the aldehydic prosthetic group was investigated using an aminooxyacetyl-conjugated cyclic RGD peptide (cyclo(RGDfK(Aoa-(Boc)) as a model peptide.

Results

The use of [18F]FDG from routine production ([18F]FDGTUM) containing an excess of d-glucose did not allow the radiosynthesis of [18F]FDG-RGD in activities >37 MBq in reasonable yield, rendering the direct use of clinical grade [18F]FDG for the routine clinical synthesis of 18F-labelled peptides impossible. Using no-carrier-added (n.c.a.) [18F]FDG obtained via HPLC separation of [18F]FDGTUM from excess glucose, however, afforded [18F]FDG-RGD in yields of 56–93% (decay corrected) and activities up to 37 MBq. Suitable reaction conditions were 20 min at 120°C and pH 2.5, and a peptide concentration of 5 mM. In a preliminary in vivo biodistribution study in M21 melanoma-bearing nude mice, [18F]FDG-RGD showed increased tumour accumulation compared to the “gold standard” [18F]galacto-RGD (2.18 vs 1.49 %iD/g, respectively, at 120 min after injection), but also slightly increased uptake in non-target organs, leading to comparable tumour/organ ratios for both compounds.

Conclusion

These data demonstrate that chemoselective 18F-labelling of aminooxy-functionalized peptides using n.c.a. [18F]FDG represents a radiofluorination/glycosylation strategy that allows preparation of 18F-labelled peptides in high yield with suitable pharmacokinetics. As soon as the necessary n.c.a. preparation of [18F]FDG prior to reaction with the Aoa-peptide can be implemented in a fully automated [18F]FDG-synthesis, [18F]fluoroglucosylation of peptides may represent a promising alternative to currently used chemoselective one-step 18F-labelling protocols.
Literatur
2.
Zurück zum Zitat Haubner R, Kuhnast B, Mang C, Weber WA, Kessler H, Wester HJ, et al. [18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates. Bioconjug Chem 2004;15:61–9. doi:10.1021/bc034170n.PubMedCrossRef Haubner R, Kuhnast B, Mang C, Weber WA, Kessler H, Wester HJ, et al. [18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates. Bioconjug Chem 2004;15:61–9. doi:10.​1021/​bc034170n.PubMedCrossRef
3.
Zurück zum Zitat Poethko T, Schottelius M, Thumshirn G, Hersel U, Herz M, Henriksen G, et al. Two-step methodology for high-yield routine radiohalogenation of peptides: (18)F-labeled RGD and octreotide analogs. J Nucl Med 2004;45:892–902.PubMed Poethko T, Schottelius M, Thumshirn G, Hersel U, Herz M, Henriksen G, et al. Two-step methodology for high-yield routine radiohalogenation of peptides: (18)F-labeled RGD and octreotide analogs. J Nucl Med 2004;45:892–902.PubMed
4.
Zurück zum Zitat Prante O, Einsiedel J, Haubner R, Gmeiner P, Wester HJ, Kuwert T, et al. 3,4,6-Tri-O-acetyl-2-deoxy-2-[18F]fluoroglucopyranosyl phenylthiosulfonate: a thiol-reactive agent for the chemoselective 18F-glycosylation of peptides. Bioconjug Chem 2007;18:254–62. doi:10.1021/bc060340v.PubMedCrossRef Prante O, Einsiedel J, Haubner R, Gmeiner P, Wester HJ, Kuwert T, et al. 3,4,6-Tri-O-acetyl-2-deoxy-2-[18F]fluoroglucopyranosyl phenylthiosulfonate: a thiol-reactive agent for the chemoselective 18F-glycosylation of peptides. Bioconjug Chem 2007;18:254–62. doi:10.​1021/​bc060340v.PubMedCrossRef
5.
Zurück zum Zitat Wuest F, Berndt M, Bergmann R, van den Hoff J, Pietzsch J. Synthesis and application of [18F]FDG-maleimidehexyloxime ([18F]FDG-MHO): a [18F]FDG-based prosthetic group for the chemoselective 18F-labeling of peptides and proteins. Bioconjug Chem 2008;19:1202–10. doi:10.1021/bc8000112.PubMedCrossRef Wuest F, Berndt M, Bergmann R, van den Hoff J, Pietzsch J. Synthesis and application of [18F]FDG-maleimidehexyloxime ([18F]FDG-MHO): a [18F]FDG-based prosthetic group for the chemoselective 18F-labeling of peptides and proteins. Bioconjug Chem 2008;19:1202–10. doi:10.​1021/​bc8000112.PubMedCrossRef
7.
Zurück zum Zitat Wester HJ, Schoultz BW, Hultsch C, Henriksen G. Fast and repetitive in-capillary production of [18F]FDG. Eur J Nucl Med Mol Imaging 2009;36:653–8.PubMedCrossRef Wester HJ, Schoultz BW, Hultsch C, Henriksen G. Fast and repetitive in-capillary production of [18F]FDG. Eur J Nucl Med Mol Imaging 2009;36:653–8.PubMedCrossRef
8.
Zurück zum Zitat Tomatis R, Marastoni M, Balboni G, Guerrini R, Capasso A, Sorrentino L, et al. Synthesis and pharmacological activity of deltorphin and demorphin-related glycopeptides. J Med Chem 1997;40:2948–52. doi:10.1021/jm970119r.PubMedCrossRef Tomatis R, Marastoni M, Balboni G, Guerrini R, Capasso A, Sorrentino L, et al. Synthesis and pharmacological activity of deltorphin and demorphin-related glycopeptides. J Med Chem 1997;40:2948–52. doi:10.​1021/​jm970119r.PubMedCrossRef
Metadaten
Titel
18F-Fluoroglucosylation of peptides, exemplified on cyclo(RGDfK)
verfasst von
Christina Hultsch
Margret Schottelius
Jörg Auernheimer
Andrea Alke
Hans-Jürgen Wester
Publikationsdatum
01.09.2009
Verlag
Springer-Verlag
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 9/2009
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-009-1122-0

Weitere Artikel der Ausgabe 9/2009

European Journal of Nuclear Medicine and Molecular Imaging 9/2009 Zur Ausgabe